Antigenic variability among two subtypes of human adenovirus serotype 7

Virus Genes

Volumn 49, Issue 1, 2014, Pages 22-29

  Tian, Xingui ^a   Su, Xiaobo ^b   Xue, Chunyan ^a   Li, Xiao ^a   Zhou, Zhichao ^a   Zhou, Rong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Epitope; Hexon; Human adenovirus serotype 7; Neutralization; Subtype

Indexed keywords

ADENOVIRUS VACCINE; EPITOPE; NEUTRALIZING ANTIBODY; CAPSID PROTEIN; HEXON CAPSID PROTEIN, ADENOVIRUS; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; CHINA; CONTROLLED STUDY; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 7; IMMUNOGLOBULIN VARIABLE REGION; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VACCINATION; VIRUS STRAIN; ADENOVIRUS INFECTION; ANIMAL; BLOOD; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; IMMUNOLOGY; ISOLATION AND PURIFICATION; RESPIRATORY TRACT INFECTION; SERODIAGNOSIS; SEROTYPE; VIROLOGY;

HUMAN ADENOVIRUS TYPE 7; MUS;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; CAPSID PROTEINS; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMANS; MICE; NEUTRALIZATION TESTS; RESPIRATORY TRACT INFECTIONS; SEROGROUP;

EID: 84905029078     PISSN: 09208569     EISSN: 1572994X     Source Type: Journal    
DOI: 10.1007/s11262-014-1071-y     Document Type: Article

References (30)

1. L. Lenaerts, E. De Clercq, L. Naesens, Clinical features and treatment of adenovirus infections. Rev. Med. Virol. 18(6), 357-374 (2008)
2. A.T. Pavia, Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin. Infect. Dis. 52(Suppl 4), S284-S289 (2011)
3. J.E. Tate, M.L. Bunning, L. Lott, X. Lu, J. Su, D. Metzgar, L. Brosch, C.A. Panozzo, V.C. Marconi, D.J. Faix, M. Prill, B. Johnson, D.D. Erdman, V. Fonseca, L.J. Anderson, M.A. Widdowson, Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J. Infect. Dis. 199(10), 1419-1426 (2009)
4. M.P. Walsh, J. Seto, E.B. Liu, S. Dehghan, N.R. Hudson, A.N. Lukashev, O. Ivanova, J. Chodosh, D.W. Dyer, M.S. Jones, D. Seto, Computational analysis of two species C human adenoviruses provides evidence of a novel virus. J. Clin. Microbiol. 49(10), 3482-3490 (2011)
5. L.J. Rojas, C.A. Jaramillo, M.F. Mojica, M.P. Escalante, P. Delgado, Molecular typing of adenovirus circulating in a Colombian paediatric population with acute respiratory infection. Epidemiol. Infect. 140(5), 818-822 (2012)
6. P.R. Barrero, L.E. Valinotto, E. Tittarelli, A.S. Mistchenko, Molecular typing of adenoviruses in pediatric respiratory infections in Buenos Aires, Argentina (1999-2010). J. Clin. Virol. 53(2), 145-150 (2012)
7. J.S. Ampuero, V. Ocana, J. Gomez, M.E. Gamero, J. Garcia, E.S. Halsey, V.A. Laguna-Torres, Adenovirus respiratory tract infections in Peru. PLoS One 7(10), e46898 (2012)
8. L. Guo, R. Gonzalez, H. Zhou, C. Wu, G. Vernet, Z. Wang, J. Wang, Detection of three human adenovirus species in adults with acute respiratory infection in China. Eur. J. Clin. Microbiol. Infect. Dis. 31(6), 1051-1058 (2012)
9. D.D. Erdman, W. Xu, S.I. Gerber, G.C. Gray, D. Schnurr, A.E. Kajon, L.J. Anderson, Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerg. Infect. Dis. 8(3), 269-277 (2002)
10. W.J. Lee, C. Kang, Y.S. Chung, K. Kim, Molecular classification of human adenovirus type 7 isolated from acute respiratory disease outbreak (ARD) in Korea, 2005-2006. Osong Public Health Res. Perspect. 1(1), 10-16 (2010)
11. T.P. Tsou, B.F. Tan, H.Y. Chang, W.C. Chen, Y.P. Huang, C.Y. Lai, Y.N. Chao, S.H. Wei, M.N. Hung, L.C. Hsu, C.Y. Lu, P.L. Shao, J.J. Mu, L.Y. Chang, M.T. Liu, L.M. Huang, Community outbreak of adenovirus, Taiwan, 2011. Emerg. Infect. Dis. 18(11), 1825-1832 (2012)
12. L. Tang, L. Wang, X. Tan, W. Xu, Adenovirus serotype 7 associated with a severe lower respiratory tract disease outbreak in infants in Shaanxi Province, China. Virol. J. 8, 23 (2011)
13. C.Y. Lai, C.J. Lee, C.Y. Lu, P.I. Lee, P.L. Shao, E.T. Wu, C.C. Wang, B.F. Tan, H.Y. Chang, S.H. Hsia, J.J. Lin, L.Y. Chang, Y.C. Huang, L.M. Huang, Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan, 2010-2011. PLoS One 8(1), e53614 (2013)
14. R.N. Potter, J.A. Cantrell, C.T. Mallak, J.C. Gaydos, Adenovirus-associated deaths in US military during postvaccination period, 1999-2010. Emerg. Infect. Dis. 18(3), 507-509 (2012)
15. R.A. Kuschner, K.L. Russell, M. Abuja, K.M. Bauer, D.J. Faix, H. Hait, J. Henrick, M. Jacobs, A. Liss, J.A. Lynch, Q. Liu, A.G. Lyons, M. Malik, J.E. Moon, J. Stubbs, W. Sun, D. Tang, A.C. Towle, D.S. Walsh, D. Wilkerson, A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in US military recruits. Vaccine 31(28), 2963-2971 (2013)
16. C.H. Hoke Jr, C.E. Snyder Jr, History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system. Vaccine 31(12), 1623-1632 (2013)
17. A. Purkayastha, J. Su, J. McGraw, S.E. Ditty, T.L. Hadfield, J. Seto, K.L. Russell, C. Tibbetts, D. Seto, Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease. J. Clin. Microbiol. 43 (7), 3083-3094 (2005)
18. Q. Li, G. Wadell, Genetic variability of hexon loops 1 and 2 between seven genome types of adenovirus serotype 7. Arch. Virol. 144(9), 1739-1749 (1999)
19. Q.G. Li, G. Wadell, Analysis of 15 different genome types of adenovirus type 7 isolated on five continents. J. Virol. 60(1), 331-335 (1986)
20. Q.G. Li, Q.J. Zheng, Y.H. Liu, G. Wadell, Molecular epidemiology of adenovirus types 3 and 7 isolated from children with pneumonia in Beijing. J. Med. Virol. 49(3), 170-177 (1996)
21. E.H. Choi, H.S. Kim, B.W. Eun, B.I. Kim, J.Y. Choi, H.J. Lee, T. Inada, Adenovirus type 7 peptide diversity during outbreak, Korea, 1995-2000. Emerg. Infect. Dis. 11(5), 649-654 (2005)
22. L.K. Crawford-Miksza, R.N. Nang, D.P. Schnurr, Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease. J. Clin. Microbiol. 37(4), 1107-1112 (1999)
23. X. Tian, X. Su, H. Li, X. Li, Z. Zhou, W. Liu, R. Zhou, Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon. Virus Res. 160(1-2), 214-220 (2011)
24. B. Yu, J. Dong, C. Wang, Y. Zhan, H. Zhang, J. Wu, W. Kong, X. Yu, Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera. Virology 437(2), 118-123 (2013)
25. H. Wu, I. Dmitriev, E. Kashentseva, T. Seki, M. Wang, D.T. Curiel, Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon. J. Virol. 76(24), 12775-12782 (2002)
26. J.J. Rux, P.R. Kuser, R.M. Burnett, Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J. Virol. 77 (17), 9553-9566 (2003)
27. H. Qiu, X. Li, X. Tian, Z. Zhou, K. Xing, H. Li, N. Tang, W. Liu, P. Bai, R. Zhou, Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions. J. Virol. 86(15), 7964-7975 (2012)
28. R.R. Bradley, L.F. Maxfield, D.M. Lynch, M.J. Iampietro, E.N. Borducchi, D.H. Barouch, Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions. J. Virol. 86(2), 1267-1272 (2012)
29. X.H. Yuan, Y.C. Wang, W.J. Jin, B.B. Zhao, C.F. Chen, J. Yang, J.F. Wang, Y.Y. Guo, J.J. Liu, D. Zhang, L.L. Gong, Y.W. He, Structure-based high-throughput epitope analysis of hexon proteins in B and C species human adenoviruses (HAdVs). PLoS One 7(3), e32938 (2012)
30. X. Tian, C. Li, C. Xue, X. Li, Z. Zhou, R. Zhou, Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3. Virus Res. 177(2), 189-193 (2013)